» Articles » PMID: 22292523

FGF/FGFR Signaling in Bone Formation: Progress and Perspectives

Overview
Journal Growth Factors
Publisher Informa Healthcare
Specialty Biology
Date 2012 Feb 2
PMID 22292523
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Fibroblast growth factors (FGFs) are important molecules that control bone formation. FGF act by activating FGF receptors (FGFRs) and downstream signaling pathways that control cells of the osteoblast lineage. Recent advances have been made in the identification of FGF/FGFR signaling pathways that control osteogenesis. Indeed, studies of mouse and human models provided novel insights into the signaling pathways that control bone formation. Genomic studies also highlighted the implication of molecular targets of FGF/FGFR signaling regulating osteoblastogenesis. Recent studies further revealed the important role of crosstalks between FGF/FGFR signaling and other signaling pathways in the regulation of osteogenesis. Finally, the importance of the mechanisms modulating FGFR degradation in the control of osteoblast differentiation has been recently revealed. This short review summarizes the recently described mechanisms underlying FGF/FGFR signaling that are involved in the control of osteoblastogenesis. This knowledge may have potential therapeutic implications in skeletal disorders characterized by abnormal bone formation.

Citing Articles

Investigating the potential effect of Holothuria scabra extract on osteogenic differentiation in preosteoblast MC3T3-E1 cells.

Songkoomkrong S, Nonkhwao S, Duangprom S, Saetan J, Manochantr S, Sobhon P Sci Rep. 2024; 14(1):26415.

PMID: 39488645 PMC: 11531581. DOI: 10.1038/s41598-024-77850-4.


Safety and tolerability of intravitreal umedaptanib pegol (anti-FGF2) for neovascular age-related macular degeneration (nAMD): a phase 1, open-label study.

Pereira D, Akita K, Bhisitkul R, Nishihata T, Ali Y, Nakamura E Eye (Lond). 2023; 38(6):1149-1154.

PMID: 38040965 PMC: 11009303. DOI: 10.1038/s41433-023-02849-6.


A Review of the Role of Tendon Stem Cells in Tendon-Bone Regeneration.

Chen J, Jiang C, Yin L, Liu Y, He Y, Li S Med Sci Monit. 2023; 29:e940805.

PMID: 37715366 PMC: 10508086. DOI: 10.12659/MSM.940805.


Enhanced Bone Formation by Rapidly Formed Bony Wall over the Bone Defect Using Dual Growth Factors.

Park J, Jung N, Lee D, Oh S, Kim S, Cho S Tissue Eng Regen Med. 2023; 20(5):767-778.

PMID: 37079199 PMC: 10352230. DOI: 10.1007/s13770-023-00534-z.


Downregulated FGFR3 Expression Inhibits In Vitro Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells of Mice with TBXT Gene Mutation.

Su H, Yang G, Yang H, Liu M, Li X, Chen L Bull Exp Biol Med. 2023; 174(4):578-584.

PMID: 36913092 DOI: 10.1007/s10517-023-05750-0.